Biocept Inc. is a molecular diagnostics company that develops and commercializes liquid biopsy tests for cancer patients. Its innovative technology allows for the detection of genetic mutations and alterations in a patient’s blood sample, aiding in the personalized treatment of various types of cancer. The company’s tests are highly sensitive and have the potential to greatly improve patient outcomes and reduce healthcare costs.
